Hindustan Zinc is pivoting towards becoming a future-ready energy transition company, Chairperson Priya Agarwal Hebbar announced. The firm ...

The US Justice Department has reportedly ended its criminal investigation into Abbott Laboratories concerning its baby formula plant, which...

Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...

By converting global risk signals into actionable growth edges, Indian businesses can not only safeguard their operations but also position...

Indian chemical industry leaders are urging a policy overhaul to boost competitiveness ahead of World MSME Day 2026. They highlight the nee...

India is set to revise rules for imported medicines, proposing a 12-month minimum residual shelf life instead of the current 60% rule. This...

According to a high-ranking official from the US, there is a strong partnership between India and the US in fortifying global AI supply cha...

As the second-largest employment generator in the country, the textile sector’s contribution to the economy is crucial, with MSMEs forming ...

Corporate India's profitability impact from the West Asia conflict is now expected to be half of initial fears, with Crisil Ratings predict...

The Union Health Ministry is proposing to relax import rules for medicines, requiring a minimum 12-month shelf life upon arrival instead of...

India's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...

Chile, a major global player in critical minerals like copper and lithium, presents a compelling strategic alliance opportunity for India. ...

India's electronics manufacturing sector is poised for decades of growth, fueled by global supply chain shifts and government support. Expe...

Niti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...

India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...

Beijing, a dominant supplier, has retaliated against potential restrictions with export controls. While China attributes its competitivenes...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...